시장보고서
상품코드
1626128

세계의 여성 건강용 치료제 시장(2024-2028년)

Global Women Health Therapeutics Market 2024-2028

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 180 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

여성 건강용 치료제 시장(2024-2028년)

여성 건강용 치료제 시장은 2023년부터 2028년까지 372억 달러 규모로 확대되며, 예측 기간 동안 6%의 CAGR로 성장할 것으로 예측됩니다. 여성 건강용 치료제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 여성 건강에 대한 관심 증가, 강력한 의약품 승인, 전략적 제휴에 의해 주도되고 있습니다.

시장 범위
기준 연도 2024년
종료 연도 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
전년 대비(2024년) 5.6%
CAGR 6%
증분 금액 372억 달러

이 보고서는 향후 몇 년 동안 여성 건강용 치료제 시장의 성장을 이끄는 주요 요인 중 하나로 부인과 질환에 대한 인식의 증가를 꼽고 있습니다. 또한, 새로운 치료법의 출현과 항생제 내성에 대한 정부의 노력이 증가함에 따라 시장 수요가 크게 증가할 것으로 예상됩니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 Technavio에 의한 분석

  • 가격 민감도·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
  • 인풋의 중요성과 차별화 요인
  • 혼란 요인
  • 성장 촉진요인과 과제의 영향

제3장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 밸류체인 분석

제4장 시장 규모 평가

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망(2023-2028년)

제5장 시장 규모 실적

  • 세계의 여성 건강용 치료제 시장(2018-2022년)
  • 종류별 분석(2018-2022년)
  • 지역별 분석(2018-2022년)
  • 국가별 분석(2018-2022년)

제6장 정성 분석

  • AI의 영향 : 세계의 여성 건강용 치료제 시장

제7장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 상황

제8장 시장 구분 : 종류별

  • 시장 구분
  • 비교 : 종류별
  • 생식 능력 : 시장 규모와 예측(2023-2028년)
  • 종양학 : 시장 규모와 예측(2023-2028년)
  • 폐경 : 시장 규모와 예측(2023-2028년)
  • 감염 : 시장 규모와 예측(2023-2028년)
  • 기타 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 종류별

제9장 고객 상황

  • 고객 상황 개요

제10장 지역별 상황

  • 지역별 구분
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 영국 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 캐나다 : 시장 규모와 예측(2023-2028년)
  • 프랑스 : 시장 규모와 예측(2023-2028년)
  • 일본 : 시장 규모와 예측(2023-2028년)
  • 멕시코 : 시장 규모와 예측(2023-2028년)
  • 한국 : 시장 규모와 예측(2023-2028년)
  • 브라질 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 지역 상황별

제11장 촉진요인, 과제, 기회, 억제요인

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 기회·억제요인

제12장 경쟁 구도

  • 개요
  • 경쟁 구도
  • 혼란 상황
  • 업계 리스크

제13장 경쟁 분석

  • 기업 개요
  • 기업 순위 지수
  • 기업의 시장 포지셔닝
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • ICON plc
  • Merck KGaA
  • Mithra Pharmaceuticals SA
  • Novartis AG

제14장 부록

ksm 25.02.04

Women Health Therapeutics Market 2024-2028

The women health therapeutics market is forecasted to grow by USD 37.2 bn during 2023-2028, accelerating at a CAGR of 6% during the forecast period. The report on the women health therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing attention toward women health, array of strong drug approvals, and strategic alliances.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.6%
CAGR6%
Incremental Value$37.2 bn

Technavio's women health therapeutics market is segmented as below:

By Type

    • Fertility
    • Oncology
    • Menopause
    • Infection
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the rising awareness of gynecological diseases as one of the prime reasons driving the women health therapeutics market growth during the next few years. Also, emergence of novel therapies and rising government initiatives to antibiotic resistance will lead to sizable demand in the market.

The report on the women health therapeutics market covers the following areas:

    • Women Health Therapeutics Market sizing
    • Women Health Therapeutics Market forecast
    • Women Health Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading women health therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Mithra Pharmaceuticals SA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Tsumura and Co., and Vivesto AB. Also, the women health therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Women Health Therapeutics Market 2018 - 2022
    • Historic Market Size - Data Table on Global Women Health Therapeutics Market 2018 - 2022 ($ billion)
  • 5.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • 5.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 5.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Women Health Therapeutics Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 Fertility - Market size and forecast 2023-2028
    • Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
    • Chart on Fertility - Year-over-year growth 2023-2028 (%)
    • Data Table on Fertility - Year-over-year growth 2023-2028 (%)
  • 8.4 Oncology - Market size and forecast 2023-2028
    • Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oncology - Year-over-year growth 2023-2028 (%)
    • Data Table on Oncology - Year-over-year growth 2023-2028 (%)
  • 8.5 Menopause - Market size and forecast 2023-2028
    • Chart on Menopause - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Menopause - Market size and forecast 2023-2028 ($ billion)
    • Chart on Menopause - Year-over-year growth 2023-2028 (%)
    • Data Table on Menopause - Year-over-year growth 2023-2028 (%)
  • 8.6 Infection - Market size and forecast 2023-2028
    • Chart on Infection - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Infection - Market size and forecast 2023-2028 ($ billion)
    • Chart on Infection - Year-over-year growth 2023-2028 (%)
    • Data Table on Infection - Year-over-year growth 2023-2028 (%)
  • 8.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 8.8 Market opportunity by Type
    • Market opportunity by Type ($ billion)
    • Data Table on Market opportunity by Type ($ billion)

9 Customer Landscape

  • 9.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

  • 10.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 10.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 10.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 10.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 10.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 10.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 10.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 10.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 10.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 10.11 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 10.12 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ billion)
    • Data Table on France - Market size and forecast 2023-2028 ($ billion)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 10.13 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 10.14 Mexico - Market size and forecast 2023-2028
    • Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
    • Chart on Mexico - Year-over-year growth 2023-2028 (%)
    • Data Table on Mexico - Year-over-year growth 2023-2028 (%)
  • 10.15 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ billion)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ billion)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 10.16 Brazil - Market size and forecast 2023-2028
    • Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Chart on Brazil - Year-over-year growth 2023-2028 (%)
    • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • 10.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

  • 11.1 Market drivers
  • 11.2 Market challenges
  • 11.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 11.4 Market opportunities/restraints

12 Competitive Landscape

  • 12.1 Overview
  • 12.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 12.3 Landscape disruption
    • Overview on factors of disruption
  • 12.4 Industry risks
    • Impact of key risks on business

13 Competitive Analysis

  • 13.1 Companies profiled
    • Companies covered
  • 13.2 Company ranking index
    • Company ranking index
  • 13.3 Market positioning of companies
    • Matrix on companies position and classification
  • 13.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 13.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 13.6 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
    • SWOT
  • 13.7 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 13.8 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 13.9 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 13.10 ICON plc
    • ICON plc - Overview
    • ICON plc - Product / Service
    • ICON plc - Key offerings
    • SWOT
  • 13.11 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 13.12 Mithra Pharmaceuticals SA
    • Mithra Pharmaceuticals SA - Overview
    • Mithra Pharmaceuticals SA - Product / Service
    • Mithra Pharmaceuticals SA - Key offerings
    • SWOT
  • 13.13 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT

14 Appendix

  • 14.1 Scope of the report
  • 14.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 14.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 14.4 Research methodology
    • Research methodology
  • 14.5 Data procurement
    • Information sources
  • 14.6 Data validation
    • Data validation
  • 14.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 14.8 Data synthesis
    • Data synthesis
  • 14.9 360 degree market analysis
    • 360 degree market analysis
  • 14.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제